David Lovejoy

David Lovejoy

Macquarie University - Sydney / Australia
Engineering & Technology / Biomedical Engineering
AD Scientific Index ID: 49556
person_outline David Lovejoy's MOST POPULAR ARTICLES
1-) Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitorsY Yu, DS Kalinowski, Z Kovacevic, AR Siafakas, PJ Jansson, C Stefani, ...Journal of medicinal chemistry 52 (17), 5271-5294, 20094082009
2-) Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessmentJ Yuan, DB Lovejoy, DR RichardsonBlood 104 (5), 1450-1458, 20044052004
3-) Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activityDR Richardson, PC Sharpe, DB Lovejoy, D Senaratne, DS Kalinowski, ...Journal of medicinal chemistry 49 (22), 6510-6521, 20063892006
4-) Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agentsDR Richardson, DS Kalinowski, S Lau, PJ Jansson, DB LovejoyBiochimica et Biophysica Acta (BBA)-General Subjects 1790 (7), 702-717, 20093382009
5-) Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and-sensitive parasitesA Walcourt, M Loyevsky, DB Lovejoy, VR Gordeuk, DR RichardsonThe international journal of biochemistry & cell biology 36 (3), 401-407, 20043262004